These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7036146

  • 1. Platelet microaggregates and release of endogenous prostacyclin during the initial phase of haemodialysis.
    Leithner C, Sinzinger H, Silberbauer K, Stummvoll HK.
    Proc Eur Dial Transplant Assoc; 1981; 18():122-5. PubMed ID: 7036146
    [Abstract] [Full Text] [Related]

  • 2. Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure.
    Kyrle PA, Stockenhuber F, Brenner B, Gössinger H, Korninger C, Pabinger I, Sunder-Plassmann G, Balcke P, Lechner K.
    Thromb Haemost; 1988 Oct 31; 60(2):205-8. PubMed ID: 2975407
    [Abstract] [Full Text] [Related]

  • 3. [The level of thromboxane A2 and prostacyclin in patients with chronic kidney failure undergoing hemodialysis].
    Rud'ko IA, Kubatiev AA, Tsalenchuk IaP, Stel'makov BG.
    Ter Arkh; 1991 Oct 31; 63(6):66-8. PubMed ID: 1948751
    [Abstract] [Full Text] [Related]

  • 4. [High circulating prostacyclin levels in patients with chronic renal insufficiency (author's transl)].
    Carreras LO, Chamone DA, Vermylen J.
    Sangre (Barc); 1981 Oct 31; 26(4):427-32. PubMed ID: 7027492
    [No Abstract] [Full Text] [Related]

  • 5. [Prostacyclin versus regional heparinisation during haemodialysis (author's transl)].
    Hory B, Saunier F, Roy C, Renevier A, Kieffer Y, Saint-Hillier Y, Perol C.
    Nouv Presse Med; 1981 Oct 31; 11(32):2393-7. PubMed ID: 7050907
    [Abstract] [Full Text] [Related]

  • 6. Enhanced 6-oxo-PGF1 alpha levels in plasma during hemodialysis.
    Leithner C, Sinzinger H, Stummvoll HK, Klein K, Silberbauer K, Peskar BA.
    Prostaglandins Med; 1980 Dec 31; 5(6):425-7. PubMed ID: 6894031
    [Abstract] [Full Text] [Related]

  • 7. Prostacyclin and platelet aggregation in sickle cell disease.
    Mehta P, Albiol L.
    Pediatrics; 1982 Sep 31; 70(3):354-9. PubMed ID: 6896748
    [Abstract] [Full Text] [Related]

  • 8. Release of prostacyclin into the coronary venous blood in patients with coronary arterial disease.
    Kaijser L, Nowak J, Patrono C, Wennmalm A.
    Adv Myocardiol; 1983 Sep 31; 4():371-8. PubMed ID: 6344165
    [Abstract] [Full Text] [Related]

  • 9. Prostacyclin synthesis is stimulated by a serum factor formed during coagulation.
    Ritter JM, Ongari MA, Orchard MA, Lewis PJ.
    Thromb Haemost; 1983 Feb 28; 49(1):58-60. PubMed ID: 6342202
    [Abstract] [Full Text] [Related]

  • 10. Prostaglandins during haemodialysis treatment.
    Kovác A, Boldizsar J, Földes O, Pavlovic M.
    Mater Med Pol; 1992 Feb 28; 24(4):241-2. PubMed ID: 1308052
    [Abstract] [Full Text] [Related]

  • 11. Protection of prostacyclin-like activity in human plasma-a non-enzymatic mechanism?
    Mikhailidis DP, Mikhailidis AM, Woollard ML, Dandona P.
    Clin Sci (Lond); 1982 Feb 28; 62(2):177-81. PubMed ID: 7032807
    [Abstract] [Full Text] [Related]

  • 12. Prostacyclin concentrations in cord blood and in the newborn.
    Jacqz EM, Barrow SE, Dollery CT.
    Pediatrics; 1985 Dec 28; 76(6):954-7. PubMed ID: 3906549
    [Abstract] [Full Text] [Related]

  • 13. Role of arterial hypertension in plasma secretion of prostacyclin during renal failure in man.
    Liguori A, Napoli C, Ciafrè SA, D'Armiento FP, Di Gregorio F, Bruzzese G, Di Ieso N, Di Benedetto A, Colasanti P, Ferrara A.
    Riv Eur Sci Med Farmacol; 1992 Dec 28; 14(5):305-8. PubMed ID: 1308960
    [Abstract] [Full Text] [Related]

  • 14. Release of adenosine and prostacyclin from ischemic human hearts.
    Edlund A, Berglund B, Kaijser L, Patrono C, Sollevi A, van Dorne D, Wennmalm A.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Dec 28; 11():365-70. PubMed ID: 6221547
    [No Abstract] [Full Text] [Related]

  • 15. [Changes of platelet aggregation, serum thromboxane and prostacyclin in lung cancer and pulmonary metastatic patients following operation].
    Takeda H, Kashimura Y, Takeoka T, Hashimoto M, Tanabe T.
    Kyobu Geka; 1984 Sep 28; 37(10):773-7. PubMed ID: 6389949
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Propyl gallate-induced platelet aggregation in patients with end-stage renal disease: the influence of the haemodialysis procedure.
    Eleftheriadis T, Antoniadi G, Liakopoulos V, Tsiandoulas A, Barboutis K, Stefanidis I.
    Nephrology (Carlton); 2006 Feb 28; 11(1):3-8. PubMed ID: 16509924
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of prostacyclin infusion on haemodialysis efficiency and blood cells.
    Kuźniewski M, Sułowicz W.
    Int Urol Nephrol; 1992 Feb 28; 24(5):555-63. PubMed ID: 1459834
    [Abstract] [Full Text] [Related]

  • 20. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients.
    Ashman N, Macey MG, Fan SL, Azam U, Yaqoob MM.
    Nephrol Dial Transplant; 2003 Oct 28; 18(10):2088-96. PubMed ID: 13679485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.